Drug intelligence / Profile preview

siSRF797

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous
01

Overview

siSRF797 is a small interfering RNA (siRNA) drug candidate targeting serum response factor (SRF) mRNA. Its mechanism involves the selective silencing of the SRF gene by promoting the degradation of its messenger RNA, thereby reducing SRF protein levels. SRF is a transcription factor implicated in fibrosis and various pathologies; thus, siSRF797 is primarily being researched for disorders related to fibrosis and pathological tissue remodeling. The specific developer and manufacturing companies have not been identified in publicly available sources. siSRF797 is under preclinical or early clinical investigation; no marketing approval has been reported.

Other names
siSRF797siSRF-797siSRF 797
02

Targets

SRF (Serum response factor)

Beyond the preview

Go deeper on siSRF797.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on siSRF797.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call